Herzlich willkommen auf der DDIM-Internetseite von Ulrike Becker

 
User Photo

Ulrike Becker

ab sofort
Interim Manager seit: 07/2018
Letzte Profilaktualisierung: 12.03.2025

Kontaktdaten

Beethovenstrasse 26
D-45699 Herten
rq.rparyyrpkr-nzenuc@erxpro.rxveyh

Kurzprofil


Werdegang (Festanstellung)

Ort
Herten
Notizen
Executive Consultant - pharma excellence
Ort
Herten
Notizen
Interim Marketing Manager Sobi Rare Benign Haematology Sep 2022- Sep 2024
Interim Marketing Manager Biocryst 2021-2023
Interim Marketing Manager Alnylam 2021-2022
Full time engagement as Patient Support Manager, Marketing Manager Hypoparathyroidsm, Marketing Manager Shrot Bowel Syndrome (Takeda, 2018 - 2021)

Ort
Bale
Notizen
Global Head of Marketing Cresemba (Antifungal)
Launching an orphan drug at hospital level (Antifungal, Haematological setting) across
Europe - direct responsibility and roll out in 6 key markets
Solving country or region-specific access issues
Forecast responsibility, supply planning responsibility
Performance: Reaching market benchmark of previously launched drugs in this specific market, with less than 10% of HQ of competitors
Overachieving (2016: 25%, 2017: 28%) budgeted sales
Ort
Dreieich
Notizen
Pan EU reactivation of 2 key brands: Polyvalent immunoglobins used in
CMV infections (CMVIG) and Hepatitis B infections (HBIG)
In collaboration with country teams developing European product strategies and rolling out the respective activities
Performance: CMVIG: 30% ahead of previous year sales, HBIG: 18% ahead of prrevious year sales
Ort
Brussels
Notizen

Regional Marketing Director Anti-Infectives:

Wyeth Deutschland

Ort
Münster
Notizen
Overall responsibility for entire hospital business (anti-infective, pain therapy, transplantation) including (7 direct reports, 56 team members)
Collaboration with market access colleagues in developing market access relevant data sets and PE dossiers
Implementation of MSL structure
Set up of complete multi-level marketing program:
Performance: Best launch and best relaunch of AI product in Europe; launch strategy rolled out across EU
Total turnover in 2004: €16 M, 2007: €34 M, 2010: €57 M

Ausbildung / Studium / Weiterbildung

Bemerkungen / Besonderheiten
MSC in Genetic Engineering / Biology, TU
Kaiserslautern

Wird geladen, bitte warten...